Biolinerx (BLRX) Posts Q1 Loss of 1c/Share

Biolinerx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Biolinerx (BLRX) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• AM Best Revises Outlooks to Positive for Triangle Insurance Company
• Gartner places F5 in AI application security emerging market report